Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (
Recalled May 1, 2024 · FDA recall D-0467-2024 · Second Tokushima Factory, Otsuka Pharmaceutical
Hazard
Cross Contamination with Other Products · FDA Class III
Units
N/A
Sold at
USA nationwide.
Description
Cross Contamination with Other Products
Product
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Manufacturer(s)
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Made in
Japan
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →